Last reviewed · How we verify

NCT05204901

Using Magnetic Field Tracking to Confirm Nasogastric Tube Placement at Point of Care

Completed NA Last updated 25 April 2023
What this trial tests

NA trial testing Insertion and withdrawal of a magnetic-tipped wire into the lumen of the nasogastric tube for tracking of its position in Enteral and Supplement Feeds Adverse Reaction in 10 participants. Completed in 7 December 2022.

Timeline
4 May 2022
Primary endpoint
7 December 2022
7 December 2022

Quick facts

Lead sponsorTan Tock Seng Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment10
Start date4 May 2022
Primary completion7 December 2022
Estimated completion7 December 2022
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Tan Tock Seng Hospital

Who can join

Adults 21 to 99, any sex, with Enteral and Supplement Feeds Adverse Reaction or Gastrointestinal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a trial on the feasibility of magnetic tracking for the confirmation of nasogastric tube location in human patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Feasibility of a low-cost magnet tracking device in confirming nasogastric tube placement at point of care, a clinical trial.
    Li H, Tay KV, Liu J, Ong CYG, et al · · 2024 · PMID 38528059 · DOI 10.1038/s41598-024-57455-7

Verify or expand the search:

Other Tan Tock Seng Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05204901.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing